Literature DB >> 33635887

Perceived barriers to Chagas disease screening among a diverse group of prenatal care providers.

Helen Mahoney West1,2, Carly E Milliren3, Olivera Vragovic4, Julia R Köhler1,5, Christina Yarrington4,6.   

Abstract

BACKGROUND: Chagas disease is a vector borne infection of poverty endemic to Latin America which affects an estimated 40,000 women of child-bearing age in the United States (US). In the US Chagas disease is concentrated among individuals who have lived in endemic areas. Prenatal diagnosis and treatment are needed to prevent congenital transmission. The objective of this study was to assess perceived barriers to Chagas disease screening among prenatal care providers in Obstetrics/Gynecology and Family Medicine Departments of a tertiary care safety-net hospital caring for a significant at-risk population. METHODOLOGY/PRINCIPAL
FINDINGS: An anonymous survey was distributed to 178 Obstetrics/Gynecology and Family Medicine practitioners. Of the 66 respondents, 39% thought Chagas screening was very important, and 48% somewhat important as a public health initiative. One third judged screening patients during clinic visits as very important. Most respondents (64%) reported being familiar with Chagas disease. However, only 32% knew how to order a test and only 22% reported knowing what to do if a test was positive.
CONCLUSIONS/SIGNIFICANCE: These findings will be incorporated into measures to facilitate full implementation of Chagas screening, and can inform initiatives at other centers who wish to address this deeply neglected infection among their patient families. Greater integration of information on Chagas disease screening and treatment in medical and nursing education curricula can contribute to addressing this disease with the focus that its potentially fatal sequelae merit.

Entities:  

Mesh:

Year:  2021        PMID: 33635887      PMCID: PMC7909700          DOI: 10.1371/journal.pone.0246783

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  19 in total

1.  Chagas' Disease.

Authors:  Debora Pellegrini; Rosana Jordan; Julio E Bruetman
Journal:  N Engl J Med       Date:  2015-11-05       Impact factor: 91.245

2.  Access to care for Chagas disease in the United States: a health systems analysis.

Authors:  Jennifer Manne-Goehler; Michael R Reich; Veronika J Wirtz
Journal:  Am J Trop Med Hyg       Date:  2015-05-18       Impact factor: 2.345

3.  Chagas disease in Latin America: an epidemiological update based on 2010 estimates.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2015-02-06

Review 4.  Congenital Chagas disease: current diagnostics, limitations and future perspectives.

Authors:  Louisa A Messenger; Caryn Bern
Journal:  Curr Opin Infect Dis       Date:  2018-10       Impact factor: 4.915

5.  Survey of obstetrician-gynecologists in the United States about Chagas disease.

Authors:  Jennifer R Verani; Susan P Montgomery; Jay Schulkin; Britta Anderson; Jeffrey L Jones
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

6.  Physician awareness of Chagas disease, USA.

Authors:  Kelly K Stimpert; Susan P Montgomery
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

7.  Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas.

Authors:  Diana L Fabbro; Emmaria Danesi; Veronica Olivera; Maria Olenka Codebó; Susana Denner; Cecilia Heredia; Mirtha Streiger; Sergio Sosa-Estani
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

8.  The BENEFIT Trial: Where Do We Go from Here?

Authors:  Bernard Pecoul; Carolina Batista; Eric Stobbaerts; Isabella Ribeiro; Rafael Vilasanjuan; Joaquim Gascon; Maria Jesus Pinazo; Silvia Moriana; Silvia Gold; Ana Pereiro; Miriam Navarro; Faustino Torrico; Maria Elena Bottazzi; Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2016-02-25

9.  Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women.

Authors:  Yves Carlier; Jaime Altcheh; Andrea Angheben; Hector Freilij; Alejandro O Luquetti; Alejandro G Schijman; Manuel Segovia; Noemie Wagner; Pedro Albajar Vinas
Journal:  PLoS Negl Trop Dis       Date:  2019-10-24

Review 10.  New, improved treatments for Chagas disease: from the R&D pipeline to the patients.

Authors:  Isabela Ribeiro; Ann-Marie Sevcsik; Fabiana Alves; Graciela Diap; Robert Don; Michael O Harhay; Shing Chang; Bernard Pecoul
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07
View more
  2 in total

1.  Geospatial analysis as a tool to identify target areas for Chagas disease education for healthcare providers.

Authors:  Gerardo J Pacheco; Lawrence Fulton; Jose Betancourt; Ram Shanmugam; Paula Stigler Granados
Journal:  BMC Infect Dis       Date:  2022-07-04       Impact factor: 3.667

2.  Effect of clinician information sessions on diagnostic testing for Chagas disease.

Authors:  Helen Mahoney West; Carly E Milliren; Jennifer Manne-Goehler; Jillian Davis; Jaime Gallegos; Juan Huanuco Perez; Julia R Köhler
Journal:  PLoS Negl Trop Dis       Date:  2022-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.